{"nct_id":"NCT04738487","title":"Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2021-04-07","start_date_type":"ACTUAL","primary_completion_date":"2024-09-05","primary_completion_date_type":"ACTUAL","completion_date":"2026-01-26","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}